首页> 外文期刊>The Journal of trauma >Efficacy of hypertonic saline dextran fluid resuscitation for patients with hypotension from penetrating trauma.
【24h】

Efficacy of hypertonic saline dextran fluid resuscitation for patients with hypotension from penetrating trauma.

机译:高渗盐水右旋糖酐液体复苏对穿透性创伤引起的低血压患者的疗效。

获取原文
获取原文并翻译 | 示例
           

摘要

BACKGROUND: The purpose of this study was to assess whether the administration of hypertonic saline dextran (HSD) was detrimental when administered to patients who were hypotensive because of penetrating injuries to the torso. The administration of HSD causes an immediate and sustained increase in blood pressure that could contribute to an increase in bleeding in the presence of uncontrolled hemorrhage. We prospectively designed a series of questions to be addressed by a meta-analysis of individual patient data using a computerized data file and case report forms from a multicenter study of HSD. METHODS: The investigators were blind penetrating injuries to the torso were studied as to survival until discharge. The patients were administered 250 mL of HSD or normal saline (standard of care [SOC]) as the initial fluid therapy. RESULTS: Of the 120 patients treated with HSD, 82.5% survived compared with 75.5% for 110 SOC patients (p = 0.19). Sixty-eight percent (n = 157) of these patients required surgery.HSD treatment (n = 84) in this population improved survival, 84.5% compared with 67.1% with SOC (n = 73) (p = 0.01). HSD resulted in an increase in blood pressure and a reduction in hematocrit, with no differences noted in fluid requirements or indices of clotting. CONCLUSION: For patients with penetrating injuries to the torso that result in hypotension, initial fluid resuscitation with HSD is beneficial in improving survival, especially if surgery is subsequently required.
机译:背景:这项研究的目的是评估高渗盐水右旋糖酐(HSD)的给药是否有害于因躯干穿透性损伤而降压的患者。 HSD的使用会导致血压的持续持续升高,在失控出血的情况下可能导致出血增加。我们前瞻性地设计了一系列问题,这些问题将通过使用计算机化数据文件和来自HSD的多中心研究的病例报告表对单个患者数据进行荟萃分析来解决。方法:研究者盲目穿透躯干受伤,研究直至出院的存活率。患者接受了250 mL HSD或生理盐水(标准护理[SOC])作为初始液体治疗。结果:在120名接受HSD治疗的患者中,存活的比例为82.5%,而110名SOC患者的存活率为75.5%(p = 0.19)。这些患者中有68%(n = 157)需要手术。该人群的HSD治疗(n = 84)改善了生存率,为84.5%,而SOC(n = 73)为67.1%(p = 0.01)。 HSD导致血压升高和血细胞比容降低,但在液体需求量或凝血指数方面未见差异。结论:对于导致低血压的躯干穿透伤患者,HSD最初的液体复苏有助于提高生存率,尤其是在随后需要手术的情况下。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号